Combination therapy versus single agent chemotherapy in non-small cell lung cancer

Author： Cheong Kerry Spicer James Chowdhury Simon Harper Peter

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.10, 2005-08, pp. : 1693-1700

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel combination chemotherapy in the treatment of non-small cell lung cancer

By Sekine I. Saijo N.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 6, 2000-09 ,pp. : 1131-1161

Informa Healthcare

Access to resources Recommend Favorite

Combination Chemotherapy with Docetaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer

By Schuette W.

Clinical Drug Investigation, Vol. 21, Iss. 3, 2001-03 ,pp. : 161-168

Adis International

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer

Current Medicinal Chemistry, Vol. 9, Iss. 8, 2002-04 ,pp. : 893-898

Bentham Science Publishers

Access to resources Recommend Favorite

Sunitinib appears to be an effective single-agent therapy for patients with recurrent non-small-cell lung cancer

Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Picoplatin pharmacokinetics and chemotherapy of non-small cell lung cancer

By Hamilton Gerhard Olszewski Ulrike

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 10, 2013-10 ,pp. : 1381-1390

Informa Healthcare

Access to resources Recommend Favorite